Discovery and Characterization of ACT‐451840: an Antimalarial Drug with a Novel Mechanism of Action
Authors:
- 29 July 2016
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 11 (18) , 1995-2014
Abstract
More than 40 % of the world's population is at risk of being infected with malaria. Most malaria cases occur in the countries of sub‐Saharan Africa, Central and South America, and Asia. Resistance to standard therapy, including artemisinin combinations, is increasing. There is an urgent need for novel antimalarials with new mechanisms of action. In a phenotypic screen, we identified a series of phenylalanine‐based compounds that exhibit antimalarial activity via a new and yet unknown mechanism of action. Our optimization efforts culminated in the selection of ACT‐451840 [(S,E)‐N‐(4‐(4‐acetylpiperazin‐1‐yl)benzyl)‐3‐(4‐(tert‐butyl)phenyl)‐N‐(1‐(4‐(4‐cyanobenzyl)piperazin‐1‐yl)‐1‐oxo‐3‐phenylpropan‐2‐yl)acrylamide] for clinical development. Herein we describe our optimization efforts from the screening hit to the potential drug candidate with respect to antiparasitic activity, drug metabolism and pharmacokinetics (DMPK) properties, and in vivo pharmacological efficacy.Keywords
This publication has 44 references indexed in Scilit:
- Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02D malaria vaccine in infants living in a malaria-endemic regionMalaria Journal, 2013
- Global Phenotypic Screening for AntimalarialsChemistry & Biology, 2012
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African ChildrenNew England Journal of Medicine, 2011
- Intrahost modeling of artemisinin resistance in Plasmodium falciparumProceedings of the National Academy of Sciences, 2010
- Artemisinin resistance: current status and scenarios for containmentNature Reviews Microbiology, 2010
- Artemisinin antimalarials: preserving the “magic bullet”Drug Development Research, 2009
- Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine CandidateJournal of Biological Chemistry, 2009
- A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human ErythrocytesPLOS ONE, 2008
- The pathogenic basis of malariaNature, 2002
- Human Malaria Parasites in Continuous CultureScience, 1976